On the other hand, the low glycolytic enzyme activity of PKM2 inhibits the conversion of pyruvate to lactate and promotes the production of glycolytic intermediates to enter the glycolysis branch pathways, thereby producing NADPH to protect tumour cells from accumulated ROS and involves in nucleotide synthesis [56]. The gene discussed is PKM; the disease is neoplasm.